Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
- 1 February 2002
- journal article
- research article
- Published by Wiley in Helicobacter
- Vol. 7 (1) , 1-8
- https://doi.org/10.1046/j.1523-5378.2002.00048.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- State-of-the-Art: Ulcer and GastritisEndoscopy, 1999
- Does eradication of Helicobacter pylori impair healing of nonsteroidal anti‐inflammatory drug associated bleeding peptic ulcers? A prospective randomized studyAlimentary Pharmacology & Therapeutics, 1998
- Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer diseaseAlimentary Pharmacology & Therapeutics, 1998
- Clinical Impact of Routine Biopsies of the Gastric Antrum and BodyEndoscopy, 1997
- Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort studyArchives of internal medicine (1960), 1996
- Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.Gut, 1996
- High‐dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.Alimentary Pharmacology & Therapeutics, 1996
- Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcerGastroenterology, 1996
- Efficacy of 12 Months' Misoprostol as Prophylaxis against IMSAID-induced Gastric Ulcers:A placebo-controlled trialScandinavian Journal of Rheumatology, 1994
- Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.BMJ, 1988